share_log

EFFECT: Others

SEC ·  Oct 7 06:03

Summary by Moomoo AI

NeuroSense Therapeutics Ltd., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on October 4, 2024. The notice, bearing the accession number 0001213900-24-083478, indicates that the company's submission type POS AM has been officially accepted. The CIK number associated with NeuroSense Therapeutics is 0001875091, and the SEC file number for this notice is 333-273375.
NeuroSense Therapeutics Ltd., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on October 4, 2024. The notice, bearing the accession number 0001213900-24-083478, indicates that the company's submission type POS AM has been officially accepted. The CIK number associated with NeuroSense Therapeutics is 0001875091, and the SEC file number for this notice is 333-273375.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more